Results 131 to 140 of about 41,377 (182)

Towards biology-informed therapies for long COVID. [PDF]

EBioMedicine
eBioMedicine.
europepmc   +1 more source

Effectiveness comparison of nirmatrelvir/ritonavir versus molnupiravir in COVID-19 patients with comorbidities in Taiwan: a multi-centre electronic health record study. [PDF]

BMC Infect Dis
Lin WK, Lin SJ, Chang YH, Wang FD, Nguyen PA, Phuc PT, Burton W, Hien NTK, Lin CC, Lam CS, Ha TC, Lu CY, Huang CW, Yang HC, Lin SM, Yang C, Wang LH, Hsu JC.   +17 more
europepmc   +1 more source

Addressing model overcomplexity in drug-drug interaction prediction with molecular fingerprints. [PDF]

J Cheminform
Gil-Sorribes M, Molina A.
europepmc   +1 more source

Effectiveness of nirmatrelvir/ritonavir and molnupiravir in reducing the risk of short-term and long-term cardiovascular complications of COVID-19: a target trial emulation study. [PDF]

Nat Commun
Guo Z, Wei Y, Lin G, Jia KM, Boyer C, Wang H, Li C, Hung CT, Yam CHK, Chow TY, Zhao S, Li K, Yang A, Mok CKP, Hui DS, Yeoh EK, Chong KC.   +16 more
europepmc   +1 more source

Ritonavir

, 2000
openaire   +1 more source